Invesco NASDAQ Future Gen 200 ETF (QQQS) — ()
Key Metrics
News
Tap Into Small-Cap Healthcare Opportunity With This ETF
Published: by:
Sentiment: Neutral ()
In an extension of a long-running theme, biotechnology stocks are disappointing investors again in 2025. Large-cap gauges addressing the industry have performed mostly in line with the S&P 500.
Read More
About Invesco NASDAQ Future Gen 200 ETF QQQS
The Invesco NASDAQ Future Gen 200 ETF (Fund) is based on the Nasdaq Innovators Completion Cap Index (Index). The Fund will invest at least 90% of its total assets in the securities that comprise the Index. The Index consists of 200 small-cap companies with the most valuable patent portfolios relative to their total market value as deemed by Nasdaq. The eligible universe consists of the companies within the Nasdaq Composite Index, excluding those companies included in the Nasdaq-100 Index and Nasdaq Next Generation 100 Index. Each constituent within the Index is equally weighted. The Fund and Index are rebalanced quarterly and reconstituted semi-annually.